Market Overview:
The global dorsal column stimulator (DCS) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of neurological disorders and rising demand for minimally invasive surgeries. Based on type, the global dorsal column stimulator (DCS) market is segmented into implantable and non-implantable devices. The implantable devices segment is further sub-segmented into spinal cord stimulators and deep brain stimulators. The non-implantable devices segment includes wearable neurostimulators and external neurostimulators. Based on application, the global dorsal column stimulator (DCS) market is divided into hospital, clinic, household and others segments. Geographically, the global dorsal column stimulator (DCS) market is analyzed across North America, Latin America, Europe Asia Pacific and Middle East & Africa regions. Some of the key players operating in this market are Medtronic plc., Boston Scientific Corporation., Stryker Corporation., Nevro Corp., Abbott Laboratories Inc., Johnson & Johnson Services Inc.
 Industry Outlook.svg)
Product Definition:
A dorsal column stimulator (DCS) is a device used to stimulate the dorsal column of the spinal cord. The dorsal column is responsible for transmitting sensory information from the body to the brain, and stimulation of this area can improve sensation and movement in people with certain injuries or conditions.
Implantable:
Implantable devices are medical devices that are placed inside the body. They help in providing relief from chronic pain by delivering electrical stimulation to the brain via spinal cord. The most common forms of implantable devices include neurostimulators and deep brain stimulators, which help in treating movement disorders such as Parkinson’s disease and epilepsy respectively.
Non-implantable:
The non-implantable device is used in the treatment of patients suffering from spinal cord injuries, chronic pain, and other neurological disorders. The DCS market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population base coupled with rising incidences of spinal cord injuries globally.
Application Insights:
The hospital segment dominated the global market in 2017. The DCS is used for treating patients with spinal cord injuries, neurological disorders, and orthopedic diseases. It has been found to be effective in improving the mobility of patients with spinal cord injuries as it helps them walk and perform daily activities easily. In addition, it helps improve bladder control and reduces pain caused by spasticity or neurogenic bladder. These factors are anticipated to drive the demand for this device over the forecast period.
DCS is also used for diagnosing conditions such as stroke, brain tumor or infection which requires motor control from brain to limb through nerve roots exit latency that lasts longer than a second which can be measured by electromyography (EMG). This device measures muscle activity through scalp electrodes that enable accurate diagnosis of various conditions affecting muscles including Parkinson¢â‚¬â„¢s disease and cerebral palsy thus driving its demand globally over the forecast period.
Regional Analysis:
North America dominated the global DCS market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of technologically advanced products, and rising preference for minimally invasive surgeries. Moreover, increasing incidence of spinal cord injuries is also expected to drive regional growth over the forecast period. According to a study published by Spinal Cord Injury Statistical Center (SCISC) in 2018, approximately 285,000 people are reported to have suffered from spinal cord injuries every year in U.S.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.8% from 2016 to 2021. This is due to the benefits offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. The Dorsal Column Stimulator (DCS) market is expected to benefit from this trend as it offers similar benefits as minimally invasive surgeries.
- Growing geriatric population: The global geriatric population is estimated to reach 1.6 billion by 2020 and 2 billion by 2030. This growing population segment is more prone to chronic diseases such as arthritis, back pain, and neurodegenerative disorders which can be treated with Dorsal Column Stimulator (DCS) devices. Thus, the Dorsal Column Stimulator (DCS) market is expected to benefit from the growing geriatric population in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dorsal Column Stimulator (DCS) Market Research Report
By Type
Implantable, Non-implantable
By Application
Hospital, Clinic, Household, Others
By Companies
Boston Scientific, Medtronic, Abbott, Nuvectra Corporation, Integer Holdings, Polar Medical, Stimwave LLC.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Dorsal Column Stimulator (DCS) Market Report Segments:
The global Dorsal Column Stimulator (DCS) market is segmented on the basis of:
Types
Implantable, Non-implantable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Medtronic
- Abbott
- Nuvectra Corporation
- Integer Holdings
- Polar Medical
- Stimwave LLC.
 Market Overview.svg)
Highlights of The Dorsal Column Stimulator (DCS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Implantable
- Non-implantable
- By Application:
- Hospital
- Clinic
- Household
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dorsal Column Stimulator (DCS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Dorsal Column Stimulator (DCS) is a medical device that uses electrical stimulation to treat chronic pain. The stimulator is placed on the skin over the back and sends electrical currents through the body, which can relieve pain.
Some of the major companies in the dorsal column stimulator (dcs) market are Boston Scientific, Medtronic, Abbott, Nuvectra Corporation, Integer Holdings, Polar Medical, Stimwave LLC..
The dorsal column stimulator (dcs) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dorsal Column Stimulator (DCS) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dorsal Column Stimulator (DCS) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dorsal Column Stimulator (DCS) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dorsal Column Stimulator (DCS) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dorsal Column Stimulator (DCS) Market Size & Forecast, 2020-2028
4.5.1 Dorsal Column Stimulator (DCS) Market Size and Y-o-Y Growth
4.5.2 Dorsal Column Stimulator (DCS) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Implantable
5.2.2 Non-implantable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Household
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dorsal Column Stimulator (DCS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dorsal Column Stimulator (DCS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Implantable
9.6.2 Non-implantable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Household
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Implantable
10.6.2 Non-implantable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Household
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Implantable
11.6.2 Non-implantable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Household
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Implantable
12.6.2 Non-implantable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Household
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Implantable
13.6.2 Non-implantable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Household
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dorsal Column Stimulator (DCS) Market: Competitive Dashboard
14.2 Global Dorsal Column Stimulator (DCS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Medtronic
14.3.3 Abbott
14.3.4 Nuvectra Corporation
14.3.5 Integer Holdings
14.3.6 Polar Medical
14.3.7 Stimwave LLC.
